Hainan Huluwa Pharmaceutical Group Co., Ltd.

SHSE:605199 Stock Report

Market Cap: CN¥7.2b

Hainan Huluwa Pharmaceutical Group Dividends and Buybacks

Dividend criteria checks 2/6

Hainan Huluwa Pharmaceutical Group is a dividend paying company with a current yield of 0.77% that is well covered by earnings.

Key information

0.8%

Dividend yield

n/a

Buyback Yield

Total Shareholder Yieldn/a
Future Dividend Yieldn/a
Dividend Growth43.9%
Next dividend pay daten/a
Ex dividend daten/a
Dividend per shareCN¥0.125
Payout ratio43%

Recent dividend and buyback updates

No updates

Recent updates

Hainan Huluwa Pharmaceutical Group Co., Ltd.'s (SHSE:605199) 43% Share Price Surge Not Quite Adding Up

Nov 29
Hainan Huluwa Pharmaceutical Group Co., Ltd.'s (SHSE:605199) 43% Share Price Surge Not Quite Adding Up

We Think That There Are Issues Underlying Hainan Huluwa Pharmaceutical Group's (SHSE:605199) Earnings

Nov 06
We Think That There Are Issues Underlying Hainan Huluwa Pharmaceutical Group's (SHSE:605199) Earnings

Here's Why Hainan Huluwa Pharmaceutical Group (SHSE:605199) Has A Meaningful Debt Burden

Oct 23
Here's Why Hainan Huluwa Pharmaceutical Group (SHSE:605199) Has A Meaningful Debt Burden

Hainan Huluwa Pharmaceutical Group Co., Ltd.'s (SHSE:605199) Shares Climb 27% But Its Business Is Yet to Catch Up

Sep 25
Hainan Huluwa Pharmaceutical Group Co., Ltd.'s (SHSE:605199) Shares Climb 27% But Its Business Is Yet to Catch Up

There's Reason For Concern Over Hainan Huluwa Pharmaceutical Group Co., Ltd.'s (SHSE:605199) Massive 27% Price Jump

Sep 25
There's Reason For Concern Over Hainan Huluwa Pharmaceutical Group Co., Ltd.'s (SHSE:605199) Massive 27% Price Jump

Risks To Shareholder Returns Are Elevated At These Prices For Hainan Huluwa Pharmaceutical Group Co., Ltd. (SHSE:605199)

Jun 07
Risks To Shareholder Returns Are Elevated At These Prices For Hainan Huluwa Pharmaceutical Group Co., Ltd. (SHSE:605199)

Hainan Huluwa Pharmaceutical Group's (SHSE:605199) Shareholders Have More To Worry About Than Only Soft Earnings

May 03
Hainan Huluwa Pharmaceutical Group's (SHSE:605199) Shareholders Have More To Worry About Than Only Soft Earnings

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: 605199 has been paying a dividend for less than 10 years and during this time payments have been volatile.

Growing Dividend: 605199 has only been paying a dividend for 4 years, and since then payments have fallen.


Dividend Yield vs Market

Hainan Huluwa Pharmaceutical Group Dividend Yield vs Market
How does 605199 dividend yield compare to the market?
SegmentDividend Yield
Company (605199)0.8%
Market Bottom 25% (CN)0.5%
Market Top 25% (CN)2.1%
Industry Average (Pharmaceuticals)1.8%
Analyst forecast (605199) (up to 3 years)n/a

Notable Dividend: 605199's dividend (0.77%) is higher than the bottom 25% of dividend payers in the CN market (0.53%).

High Dividend: 605199's dividend (0.77%) is low compared to the top 25% of dividend payers in the CN market (2.07%).


Earnings Payout to Shareholders

Earnings Coverage: With its reasonably low payout ratio (43%), 605199's dividend payments are well covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: 605199 is paying a dividend but the company has no free cash flows.


Discover strong dividend paying companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 08:48
End of Day Share Price 2024/12/23 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Hainan Huluwa Pharmaceutical Group Co., Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution